navigating biosimilars: biologics and biosimilars (gray line)
Published 6 years ago • 33 plays • Length 10:00Download video MP4
Download video MP3
Similar videos
-
8:32
navigating biosimilars: implications for clinicians (red line)
-
3:39
navigating biosimilars: biologics landscape (orange line)
-
0:50
navigating biosimilars: introduction
-
6:31
navigating biosimilars: patient education (green line)
-
10:58
navigating biosimilars: us regulatory requirements (yellow line)
-
8:03
navigating biosimilars: extrapolation, naming, substitution (blue line)
-
38:15
biosimilars and biologics
-
35:31
understanding biosimilars: how the availability of biosimilars will impact clinical practice
-
3:48
module 2: biosimilars—advances in research and development
-
0:41
similarity of biosimilars and biologics
-
17:57
understanding biosimilars: differences between biosimilars and reference products
-
6:43
biosimilars
-
0:57
what's the difference between a biologic and a biosimilar?
-
2:04
biosimilars: the path to approval
-
4:46
module 3: biosimilars—advances in research and development
-
6:24
module 4: biosimilars—advances in research and development
-
8:10
module 6: biosimilars—advances in research and development
-
0:59
how do i talk to my doctor about starting a biosimilar?